Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba for ECT-induced Memory Deficits
NCT00070954Phase 2Terminated
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2003
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cognitive impairment comparing Ginkgo Biloba with Placebo (2 arms). Primary endpoints: Modified Mini-Mental State Examination, Rey Auditory Verbal Learning Test and 3 more. Started Feb 2003; status: terminated.
02
Drugs
ginkgo biloba extract
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT00070954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070954.